SMMIL-E Workshop on

BioMEMS technologies against Cancer

December 15, 2017.


- Espace Baïetto -

CNRS délégation Nord Pas de Calais et Picardie,

2 rue des Canonniers, 59046 Lille

14:00 – 17:30

SMMIL-E Workshop on BioMEMS technologies against Cancer, Friday December 15th

The SMMIL-E project is expanding the BioMEMS activities performed in IIS/The University of Tokyo and LIMMS/CNRS-IIS towards the research against cancer conducted in Lille. The convergence of BioMEMS with a comprehensive research against Cancer opens a promising scientific investigation domain especially as the research against cancer pursued in Lille was endorsed by the National Cancer Institute under the SIRIC ONCOLille program.

The SMMiL-E project is supported by CNRS, IIS/Tokyo, Centre Oscar Lambret and the University of Lille.  This program is diffusing towards the main actors involved in the CPER Cancer, a top priority joint program of the new region Hauts de France with French state.

After the successful event in Dec. 15, 2016 in Tokyo, this workshop aims to push the BioMEMS opportunities beyond the current labelled projects by:

-    surveying very new bioMEMS opportunities available in the framework,

-    listening new project opportunities, marks of interest by new actors from academics and industries. 

BioMEMS reviews are given by prominent lecturer from IIS/The university of Tokyo, LIMMS/CNRS-IIS and BMBI/UTCompiègne-CNRS. This workshop is open to all colleagues interested in BioMEMS as a new technology opportunity and for development in their activities towards bio/medical applications for cancer research. 





Opening session


Workshop aim and strategy by Pr. Dominique Collard, Pr. Hiroyuki Fujita, LIMMS/CNRS-IIS (10 min)


Session 1: Bio-MEMS opportunities (1)

  • Microfluidic liver on chip with IPS technologies(25+5 min)
    Dr. Eric Leclerc, LIMMS/CNRS-IIS
  • Organ on chip applications at UTC (25+5 min.)
    Dr. Cécile Legallais, BMBI UMR CNRS 7338, UTC, Compiègne
  • Realistic tumour environment for in vitro liver Cancer model (tentative)(new opportunity) (10 min)
    Pr. Anthony Treizebré, IEMN
  • Development of a low-grade neoplasia in a 3D culture model after infection with the intestinal parasite Cryptosporidium parvum. (new opportunity) (10 min)
    Martha Baydoun, Institut Pasteur/ Ciil/IEMN/ISA-Groupe Yncréa.

Coffee break

16:00 Session 2: Bio-MEMS opportunities (2)
  • Advanced MEMS / BioMEMS for future cancer related application (tentative title)
    Pr. Hiroyuki Fujita, IIS The University of Tokyo (20+5 min.)
  • New microfluidic platform for tissue engineering (tentative title)
    Pr. Shoji Takeuchi, IIS The University of Tokyo (20+5 min.)
  • Why and how HCS Pharma wants to improve relevance of screening models in drug discovery : application in oncology(new opportunity)
    Nathalie MAUBON, Elodie Vandenhaute, Marie Lesaffre, HCS Pharma (10 min)
  • Tumor and angiogenesis in 3D model. (tentative title)(new opportunity) (10 min)
    Fabrice Soncin, UMR 8161 IBL (10 min)

Closing session 

  • Final remarks and steps beyond  by SMMiL-E Research Direction
    Pr. Teru Okitsu, IIS The University of Tokyo and Dr. Eric Leblanc, Centre Oscar Lambret.





Captcha Code

Click the image to see another captcha.

Workshop Location